Marco Failla

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Imperial College London18.8%
• GlaxoSmithKline (United Kingdom)10.2%
• University of Catania9.5%
• Lung Institute8.1%
• Inserm6.8%
• Hunter Medical Research Institute5.7%
• Other41%

Fields

• Medicine76.3%
• Biochemistry, Genetics and Molecular Biology19.2%
• Immunology and Microbiology2.3%
• Neuroscience0.8%
• Chemistry0.3%
• Computer Science0.3%
• Other0.8%

Topics

• Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis29.3%
• Chronic Obstructive Pulmonary Disease (COPD) Research12.5%
• Asthma and respiratory diseases11.8%
• Neonatal Respiratory Health Research6.3%
• Sarcoidosis and Beryllium Toxicity Research6.3%
• Lung Cancer Treatments and Mutations4.4%
• Other29.5%